ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Agomelatine improves symptom severity and quality of life in diarrhea-predominant irritable bowel syndrome: insights from a randomized controlled clinical trial.

Seyed Saman Talebi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.